Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $5.68 Million - $6.56 Million
-90,000 Reduced 24.32%
280,000 $19.2 Million
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $26.5 Million - $32.3 Million
370,000 New
370,000 $27.1 Million
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $2.32 Million - $2.9 Million
40,000 Added 14.29%
320,000 $19 Million
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $4.5 Million - $5.13 Million
-75,000 Reduced 21.13%
280,000 $18.1 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $1.13 Million - $1.29 Million
-20,000 Reduced 5.33%
355,000 $20.7 Million
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $3.11 Million - $3.9 Million
50,000 Added 15.38%
375,000 $23.7 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $1.09 Million - $1.26 Million
15,000 Added 4.84%
325,000 $25 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $9.86 Million - $10.8 Million
160,000 Added 106.67%
310,000 $20.1 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $9.28 Million - $10.4 Million
150,000 New
150,000 $10.1 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $4.06 Million - $4.55 Million
-65,000 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$72.84 - $88.8 $1.46 Million - $1.78 Million
-20,000 Reduced 23.53%
65,000 $4.9 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $6.05 Million - $7.1 Million
85,000
85,000 $6.09 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Lombard Odier Asset Management (Usa) Corp Portfolio

Follow Lombard Odier Asset Management (Usa) Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.